Enjoy complimentary customisation on priority with our Enterprise License!
Technavio’s analysts have identified the growing demand for monoclonal antibodies that are identical immune cells as a major factor that will drive this market during the forecast period. Several types of transfection methods in the areas of biology, medicine, and biochemistry adopt the application of monoclonal antibodies. Growing adoption of various types of transfection methods across the world is likely to further drive demand for transfection technologies. These driving factors are part of the reason why the market is expected to grow at a CAGR of nearly 9%. For a complete list of drivers influencing the market’s growth, purchase Technavio’s full report.
Want to know what goes into a Technavio report? Get a FREE sample to see selected illustrations and analysis straight from this report.
The global transfection technologies market is concentrated with international and regional companies that offer products for different types of transfection methods for pharmaceutical and biotechnology companies, contract research organizations (CRO), and academic and research institutes. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this transfection technologies industry analysis report will aid clients identify new growth opportunities and design new growth strategies.
The report offers a complete analysis of a number of companies, including:
Technavio’s market research report covers the following regions:
Almost 45% of the market’s incremental growth is expected to come from the Americas over the next five years. North America will dominate the market in this region, driven by factors such as increasing cases of infectious diseases demanding the need of antibiotics and growing use of cell-based products which require transfection methods to treat chronic diseases such as cancer, tuberculosis, and cardiovascular diseases.
The global transfection technologies market can be divided into 3 end-user categories:
In 2017, the pharmaceutical and biotechnology companies segment accounted for the largest share of the market, contributing almost 44% to it. Rising need for different types of transfection methods will mean that this segment will continue to dominate the market throughout the forecast period. The increasing cases of infectious diseases and chronic disorders are expected to drive the growth of the market. This report also examines the contributions of the other product segments to the growth of the market and offers predictions for their future performance.
Technavio also provides customized reports based on the specific requirement of our clients
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY END-USER
PART 09: REGIONAL LANDSCAPE
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSIS
PART 15: APPENDIX
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.